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Summary 
The receptor mechanisms mediating the retrograde 
axonal transport of the neurotrophins have been inves- 
tigated in adult rats. We show that transport of the 
TrkB ligands NT-4 and BDNF to peripheral neurons is 
dependent on the low affinity neurotrophin receptor 
(LNR). Pharmacological manipulation of LNR in vivo 
using either an anti-LNR antibody or a soluble recombi- 
nant LNR extracellular domain completely blocked ret- 
rograde transport of NT-4 and BDNF to sensory neu- 
rons, while having minimal effects on the transport of 
NGF in either sensory or sympathetic neurons. Fur- 
thermore, in mice with a null mutation of LNR, the 
transport of NT-4 and BDNF, but not NGF, was dramati- 
cally reduced. These observations demonstrate a se- 
lective role for LNR in retrograde transport of the vari- 
ous neurotrophins from distinct target regions in vivo. 
Introduction 
Target-derived neurotrophic factors promote the survival 
of specific neuronal populations and thus assist in sculp- 
ting the developing nervous system (Thoenen, 1991 ; Lind- 
say et al., 1994). The neurotrophins--nerve growth factor 
(NGF), brain-derived neurotrophic factor (BDNF), neuro- 
trophin 3 (NT-3), NT-4 (also known as NT-5), and NT-6-- 
each display a distinct spatial and temporal pattern of ex- 
pression in the targets of peripheral neurons (Leibrock et 
al., 1989; Maisonpierre et al., 1990; Berkemeier et al., 
1991 ; Hallb55k et al., 1991 ; GStz et al., 1994). However, 
it is not clear how binding of neurotrophins at axon termi- 
nals, in many cases several centimeters from the cell body, 
can regulate the survival and phenotypic expression of 
these neurons. Receptor-mediated retrograde axonal 
transport of NGF, BDNF, and NT-3 has been demon- 
strated (DiStefano et al., 1992), and translocation from 
the axon to the cell body provides a mechanism whereby 
neurotrophic factors can influence somal signal transduc- 
tion (Curtis and DiStefano, 1994). Additionally, recent evi- 
dence suggests that neurotrophins may also be synthe- 
sized within certain neuronal populations (Emfors et al., 
1990; Schecterson and Bothwell, 1992)and therefore ex- 
ert paracrine or autocrine effects on neuronal survival 
(Acheson et al., 1995). 
The retrograde axonal transport of NT-4 has yet to be 
characterized in adult peripheral neurons. NT-4 is widely 
expressed in peripheral tissues, including muscle, skin, 
and nerve (Funakoshi et al., 1993; IbdSez et al., 1993; 
Timmusk et al., 1993). NT-4 promotes the survival of cul- 
tured embryonic sensory neurons (Davies et al., 1993a; 
Ib&Sez et al., 1993; Fandl et al., 1994) and rescues axotom- 
ized facial motor neurons in neonatal rats (Koliatsos et al., 
1994). NT-4 additionally preserves the cholinergic pheno- 
type of cultured embryonic motor neurons (Wong et al., 
1993) and of axotomized adult motor neurons (Friedman 
et al., 1995). Here, we report the retrograde axonal trans- 
port of NT-4 in adult sensory and motor neurons and de- 
scribe a novel receptor mechanism for the transport of 
NT-4 and BDNF. 
Neurons display two pharmacologically distinct neuro- 
trophin-binding sites (Meakin and Shooter, 1992). The low 
affinity binding site (KD -- 10 -9 M) is most likely accounted 
for by a transmembrane protein known as p75 or low affin- 
ity NGF receptor (Chao et al., 1986; Radeke et al., 1987), 
herein termed low affinity neurotrophin receptor (LNR). All 
neurotrophins are able to bind competitively to this re- 
ceptor (Squinto et al., 1991), although association and 
dissociation rate constants of binding differ among the 
neurotrophins (Rodriguez-T6bar et al., 1990, 1992). Neu- 
rotrophin-dependent differentiation and survival have not 
been demonstrated in cells expressing only LNR (Glass 
and Yancopoulos, 1993), although it has recently been 
shown that binding of neurotrophins to LNR can activate 
signaling through the sphingomyelin pathway (Dobrowsky 
et al., 1994). Higher affinity binding of the neurotrophins 
along with cell survival and phenotypic responses are con- 
ferred by the Trk family of receptor tyrosine kinases. NGF 
is the preferred ligand for TrkA, whereas TrkB is activated 
by both BDNF and NT-4. NT-3 is the preferred ligand for 
TrkC and a secondary ligand for TrkB, in that higher con- 
centrations of NT-3 are required to activate TrkB (Chao, 
1992; Klein et al., 1992; Glass and Yancopoulos, 1993). 
Binding of neurotrophins results in homodimerization and 
autophosphorylation ofTrk proteins and in initiation of sig- 
nal transduction cascades involving the MAP kinases as 
well as cytosolic transcription factors (Curtis and DiStef- 
ano, 1994). 
The role of LNR in neurotrophin high affinity binding 
and responsiveness is currently controversial. Equilibrium 
binding studies suggest that coexpression of Trk proteins 
and LNR is required for high affinity binding (Hempstead 
et al., 1989, 1991; Battleman et al., 1993). Cell survival 
assays show enhanced responses to neurotrophins in fi- 
broblasts and sympathoadrenal progenitor cells express- 
Neuron 
1202 
ing both LNR and Trk proteins (Hantzopoulos et al., 1994; 
Verdi et al., 1994), and pharmacological manipulation of 
LNR decreased the activation of immediate-early re- 
sponses to NG F in PC12 cells (Barker and Shooter, 1994). 
In contrast, Trk proteins have been shown to mediate re- 
sponses in cells independently of LNR. For example, fibro- 
blasts transfected with individual Trk proteins bind and 
are activated by their cognate ligands in the absence of 
LNR (Glass et al., 1991; Glass and Yancopoulos, 1993). 
Also, sympathetic neurons in culture appear to respond 
to a mutant of NGF that activates TrkA but does not bind 
LNR (Ib&~ez et al., 1992), and antibodies that block NGF 
binding to LNR do not prevent neurite outgrowth of PC12 
cells in response to NGF (Weskamp and Reichardt, 1991). 
Cross-linking studies show that NGF binds TrkA homodi- 
mers, leading to autophosphorylation, while TrkA-LNR 
heterodimers have not been detected (Meakin et al., 1992; 
Jing et al., 1992), suggesting that neurotrophins are similar 
to other growth factors in activating specific receptor tyro- 
sine kinases by homodimerization (Schlessinger and UII- 
rich, 1992). Thus, the Trk proteins alone appear capable 
of mediating transmembrane signaling. While LNR may 
cooperate to increase the affinity of Trk proteins for neuro- 
trophins, the role of LNR in the context of a neuron in vivo 
remains unclear. 
Previous studies have implicated LNR in retrograde 
transport of neurotrophins. The LNR-specific monoclonal 
antibody 192-1gG augments the retrograde transport of 
NGF by sympathetic neurons (Taniuchi and Johnson, 
1985) and is itself transported by these neurons (Taniuchi 
and Johnson, 1985) as well as by sensory neurons (R. C. 
and P. S. D., unpublished data). Furthermore, the retro- 
grade transport of endogenous LNR has been demon- 
strated in rat sciatic nerve and in central forebrain choliner- 
gic pathways (Johnson et al., 1987). Recently, LNR has 
been implicated in the retrograde signaling and survival 
of chicken isthmo-optic neurons in response to BDNF and 
NT-3 (von Bartheld et al., 1994). In these studies, NGF 
enhanced the developmental death of these neurons, pre- 
sumably by interfering with survival mechanisms involving 
LNR-dependent retrograde signaling from the target. In 
this paper, we have tested directly the hypothesis that LNR 
has a role in retrograde axonal transport of the neurotro- 
phins. We propose that the transport of NT-4 and BDNF is 
particularly dependent on interactions with LNR, whereas 
the transport of NGF is relatively insensitive to manipula- 
tions of LNR. 
Results 
Retrograde Transport of NT-4 to Rat Sensory and 
Motor Neurons 
Previous studies have shown that the neurotrophins NGF, 
BDNF, and NT-3 are all retrogradely transported by spe- 
cific subpopulations of sensory neurons via distinct recep- 
tor-mediated mechanisms (DiStefano et al., 1992), consis- 
tent with the known specificities of the Trk receptors (Glass 
and Yancopoulos, 1993). To characterize the retrograde 
transport of '251-NT-4, we quantified its accumulation in 
lumbar fourth and fifth dorsal root ganglia (L4 and L5 DRG) 
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Figure 1. Retrograde Transport of 12SI-NT-4 and 12fl-BDNF: Effect of 
Unlabeled Neurotrophins 
Either 22 ng of 1251-NT-4 (A) or 44 ng of 12SI-BDNF (B) was injected 
in 2 p.I of PBS into the right sciatic nerve at the level of the obturator 
tendon. These injections contained PBS alone (0 rig) or 10-1000 ng 
of unlabeled neurotrophins. After 18 hr, the L4 and L5 DRG were 
removed and counted in a 7 counter. Results are the mean -.+ SD of 
combined counts per minute (CPM) in L4 and L5 DRG of 4-5 rats and 
are representative of at least two experiments. NGF potentiation of
NT-4 transport (and inhibition at high doses) was also observed when 
44 ng of ~251-NT-4 was injected. In (A), all doses of NGF were signifi- 
cantly different compared with PBS (p < .01 for 10 and 100 ng; p < 
.05 for 1000 rig). In (B), only the 10 ng dose was signficantly different 
from PBS (p < .01). 
after injection into the sciatic nerve. Figure 1A shows that 
12SI-NT-4 was retrogradely transported by sensory neu- 
rons; transport was inhibited in a dose-dependent fashion 
by the neurotrophins, with the rank order: NT-4 > BDNF = 
NT-3 >> NGF. Surprisingly, NGF inhibited transport at 1 
p.g (the highest dose tested), but at low doses (10 ng and 
100 ng) NGF caused a significant elevation of 1251-NT-4 
retrograde transport (Figure 1A). In contrast, NT-4 (10- 
950 ng) did not significantly affect the transport of 
12SI-NGF (data not shown). To determine whether the 
biphasic effects of NGF on transport were specific for 
12SI-NT-4, we next coinjected unlabeled NGF with 
1261-BDNF. The retrograde transport of ~251-BDNF was 
significantly elevated by 10 ng of NGF but not by 100 ng 
or 1 p.g of NGF (Figure 1B). As expected, unlabeled BDNF 
and NT-4 blocked 12SI-BDNF retrograde transport in a 
dose-dependent manner. 
Since the transport of NT-4 was inhibited by all the neu- 
rotrophins at high doses, we postulated that interactions 
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Figure 2. Retrogradely Transported 1251-NT-4 in DRG Sensory Neurons and Colocalization with LNR Immunoreactivity 
(A and B) Bright-field photomicrographs of lumbar DRG after injection of 44 ng of 1251-NT-4 (A) or 44 ng of 1251-NT-4 plus a 22-fold excess of 
unlabeled NT-4 (B). 
(C) Colocalization of LNR with retrogradely transported 12SI-NT-4. Sections (10 ~m) of DRG from animals injected intraneurally with 44 ng of 
~251-NT-4 were immunostained with 192-1gG and processed for emulsion autoradiography. Arrows, LNR-immunopositive n urons transporting 
~251-NT-4; arrowhead, neuron with minimal LNR immunoreactivity that also transported ~251-NT-4. 
Bar, 23 p.m. 
with non-TrkB receptors, such as LNR, might be involved 
in the transport of NT-4 and possibly BDNF. Two additional 
lines of indirect evidence suggested that LNR is crucial 
to NT-4 retrograde transport. The first arose from studies in 
which retrogradely accumulated ~251-NT-4 was colocalized 
with LNR immunostaining in the cell bodies of sensory 
neurons. Extensive accumulation of ~2SI-NT-4 was evident 
in small as well as large neurons in lumbar DRG (Figures 
2A and 2C). This labeling was blocked by coinjection of 
a 22-fold excess of unlabeled NT-4 (Figure 2B), corro- 
borating the quantitation i  Figure 1A. Immunostaining 
of ~251-NT-4-1abeled sections of DRG with an antibody 
against LNR (192-1gG) revealed the localization of silver 
grains over predominantly immunopositive cells. How- 
ever, '251-NT-4 accumulation was observed occasionally 
in some cells with little or no apparent LNR irnmunore- 
activity (Figure 2C). 
Further evidence for the involvement of LNR in the trans- 
port of NT-4 came from studies in adult motor neurons, 
taking advantage of the fact that hese cells normally do 
not express LNR but up-regulate its expression within 24 
hr of sciatic nerve injury (Ernfors et al., 1989; Rende et 
al., 1 992). Previous studies have shown that the other TrkB 
ligands, BDNF and NT-3, are retrogradely transported by 
normal adult motor neurons (DiStefano et al., 1992). In 
contrast, 7 counting and emulsion autoradiography of spi- 
nal cords demonstrated that intact motor neurons do not 
transport '251-NT-4, although ~2~I-NT-4 accumulated in 
motor neurons when injected 3 days after sciatic nerve 
crush (Figures 3A and 3B). NT-4 transport was first evident 
at 1 day postlesion, was maximal at 3 days (Figure 3D), 
and remained elevated 7 days after injury (data not 
shown). The accumulation of 1251-NT-4 in injured motor 
neurons was blocked by a 22-fold excess of unlabeled 
NT-4 (Figures 3C and 3D), indicating that the lesion- 
induced transport of NT-4 was receptor mediated. 
Direct Evidence for a Role of LNR in Neurotrophin 
Retrograde Transport: Pharmacological 
Manipulations 
To test directly the hypothesis that retrograde transport 
of NT-4 and BDNF requires an interaction with LNR, two 
agents were used to disrupt the function of LNR in normal 
adult rats. First, a soluble recombinant extracellular do- 
main of human LNR (designated here as sLNR; DiStefano 
et al., 1 991) was used to compete with cell surface LNR for 
neurotrophin binding, uptake, and transport. Retrograde 
transport of 12SI-NT-4, 1251-BDNF, and ~251-NT-3 was inhib- 
ited in a dose-dependent manner by coinjection with 
sLNR, whereas transport of 1251-NGF was almost com- 
pletely unaffected (Figure 4A). The rank order inhibition 
of transport by sLNR was as follows: NT-4 > BDNF > NT-3 
> NGF. Second, a polyclonal antiserum against the ex- 
tracellular domain of rat LNR (designated anti-REX; 
Weskamp and Reichardt, 1991) was used to inhibit the 
binding of neurotrophins to LNR. Anti-REX effectively 
blocked the retrograde transport of 1251-NT-4, 12~I-BDNF 
(Figure 4B), and ~251-NT-3 (data not shown), but had a 
minimal effect on the transport of ~251-NGF. The rank order 
inhibition of transport by anti-REX was as follows: NT-4 > 
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Figure 3. Adult Rat Motor Neurons Retrogradely Transport ~2SI-NT-4 Only after Sciatic Nerve Lesion 
Injections of ~2SI-NT-4 (44 ng) were made into the right sciatic nerve at the level of the obturator tendon of unlesioned rats or animals whose sciatic 
nerves had been crushed at the same site 1 or 3 days earlier. Animals were allowed to recover for 18-20 hr. 
(A-C) Emulsion autoradiography of ~2SI-NT-4 transport in motor neurons of rats with no lesion (A), 3 day lesion (B), or 3 day lesion plus a 22-fold 
excess of unlabeled NT-4 (C). Note the complete absence of NT-4 accumulation in animals receiving no lesion. Bar, 23 p.m. 
(D) Quantification of ~2~I-NT-4 retrograde transport o spinal cord in unlesioned rats (NO LEX) and in animals 1 or 3 days after sciatic nerve crush 
(1 DAY, 3 DAY). Unlabeled NT-4 competed with transport of 12SI-NT-4 (3 DAY + NT-4). Values represent he means 4- SD of 4-8 rats. 
BDNF = NT-3 > NGF. Control experiments demonstrated 
that nonspecific rabbit immunoglobulins did not inhibit 
transport of the neurotrophins (data not shown). 
To determine whether the effects of sLNR and anti-REX 
were selective for retrograde transport o spinal sensory 
neurons, we also tested these agents on transport of neu- 
rotrophins to other peripheral neurons. We chose to moni- 
tor transport from the anterior eye chamber to the superior 
cervical ganglion (SCG) and from the whisker pad to the 
trigeminal ganglion. These two systems were chosen for 
several reasons. First, transport to the SCG represents 
a nonsensory, NGF-responsive system (Johnson et al., 
1978). Second, trigeminal neurons represent a different 
class of sensory neurons that respond to NGF as well 
as to NT-4 (Ib&fiez et al., 1993). Third, in both systems 
injections of ~251-1abeled neurotrophins are made in the 
target region, as opposed to axon shafts in the case of 
experiments examining transport to DRG after sciatic 
nerve injections; this controls for the possibility that our 
observations in DRG are due to differential distributions 
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Figure 4. Dose Inhibition of 12SI-Neurotrophin 
Retrograde Transport by sLNR and Anti-REX 
(A) l~l-labeled neurotrophin (1 Id) was coin- 
jected with 1 p,I of PBS or solutions containing 
0.026-2.6 p.g of sLNR. Results are expressed 
as the mean percentage of PBS control ( 4- SD) 
of 4 animals and are representative of two such 
experiments. Counts per minute in L4 and L5 
DRG of the PBS controls for each neurotrophin 
were 11,144 (NGF), 3,172 (BDNF), 2,948 (NT- 
3), and 4,836 (NT-4). 
(B) lZSl-labeled neurotrophins (0.5 p,I) were coin- 
jected with 1.5 p.I of anti-REX solutions (0.31- 
10.5 p_g of IgG). Values are the mean percentage of PBS control 4- SD (n = 4). Counts per minute in L4 and L5 DRG of the PBS controls for 
each neurotrophin were 9,452 (NGF), 1,821 (BDNF), and 2,935 (NT-4). 
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Figure 5. Effect of Anti-REX and sLNR on Retrograde Transport of 
Neurotrophins in Trigeminal Sensory Neurons and Sympathetic 
Neurons 
(A and B) Effects of anti-REX on retrograde transport of 12SI-NT-4 (A) 
and ~251-NGF (B) to trigeminal ganglia. Injections (2 i11:0.5 p_l of 
12~l-labeled neurotrophin with 1.5 p.I of PBS, anti-REX [10.5 I~g], or 1 
~g of unlabeled neurotrophin) were made at two sites in the right 
whisker pad. Right (closed bars) and left (open bars) trigeminal ganglia 
were removed and counted 15-16 hr later. Values represent he mean 
_+ SD of 6-7 animals. Asterisk, p < .31 compared with respective 
PBS controls. 
(C) Retrograde transport of ~251-NGF to superior cervical ganglion 
(SCG). ~251-NGF (0.5 td; 22 ng) was ir~jected into the right anterior 
eye chamber with PBS (1.5 ~1), anti-REX (10.5 Ilg), sLNR (2.6 p.g), or 
unlabeled NGF (1 ~g). Right (closed bars) and left (open bars) SCGs 
were removed after 16-18 hr and counted. Values represent mean 
_+ SE of 6-7 animals. Asterisk, p < .01 compared with respective PBS 
controls. 
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of LNR and Trk proteins along sensory axon shafts versus 
their terminals. As with transport o DRG, anti-REX inhib- 
ited the transport of ~251-NT-4 from the whisker pad to sen- 
sory neurons in the trigeminal ganglion but did not affect 
12SI-NGF transport o these neurons (Figures 5A and 5B). 
Likewise, neither sLNR nor anti-REX had a significant ef- 
fect on ~251-NGF transport from the anterior eye chamber 
to sympathetic neurons of the SCG (Figure 5C) when 
tested at doses that blocked transport of ~251-NT-4 to DRG; 
however, 2.6 t~g of sLNR caused a slight, but nonsignifi- 
cant, reduction in ~251-NGF transport o SCG neurons, con- 
sistent with the limited effects of this agent on NGF trans- 
port to DRG. 
Direct Evidence for a Role of LNR in Neurotrophin 
Retrograde Transport: LNR-Null Mice 
We examined the retrograde transport of NT-4 and other 
neurotrophins in a mouse strain with a null mutation of 
the LNR gene (Lee et al., 1992). Compared with normal 
mice, these have reduced numbers of sensory neurons 
in DRG (see below), which may contribute to reduced ap- 
parent levels of retrograde transport. Therefore, we mea- 
sured the levels of retrograde transport of wheat germ 
agglutinin (WGA), which is retrogradely transported by 
many neurons following binding to cell surface glycopro- 
teins (Trowjanowski, 1983). We also measured the trans- 
port of leukemia inhibitory factor (LIF), which is transported 
by a mechanism involving receptors for the neuroactive 
cytokines (Curtis et al., 1994). Retrograde transport of both 
I~I-WGA and 1251-LIF was reduced by approximately 50% 
in LNR-null mice compared with that in the wild type (Fig- 
ure 6A and 6B). This correlates well with estimates of DRG 
neuron counts in LNR-null mice (-50%-60% of wild type; 
K.-F. L. and S. Landis, unpublished ata). It is important 
to note that, while fewer cells were labeled with 1251-WGA 
in the LNR-null mice, the intensity of cellular labeling was 
comparable to that seen in wild-type mice (data not 
shown). To show that the lack of LNR expression does 
not exert nonspecific effects on axonal transport of neuro- 
trophins per se, we measured transport of ~251-BDNF to 
spinal cord motor neurons. In normal adult rats, spinal 
motor neurons transport 12SI-BDN F (DiStefano et al., 1992) 
but do not express LNR (Ernfors et al., 1989; Rende et 
al., 1992). Transport of ~2SI-BD NF to these neurons in LNR- 
null mice was identical to that in the wild type (Figure 6C). 
Given that sensory neuron populations are reduced in 
the DRG of LNR-null mice, we expected that retrograde 
12~I.BDNF Figure 6. Retrograde Transport Is Compro- 
mised in DRG but Not Spinal Cord of LNR-Null 
Mice 
Transport of 1251-WGA (A) and 1251-LIF (B) to 
DRG and 1251-BDNF accumulation in spinal 
cord ((3) of BALB/c (+/+) and LNR-null ( - / - )  
mice. Results are the mean _+ SD of 3-4 ani- 
mals, except for WGA (n = 2). Transport of 
WGA and LIF to DRG was reduced by approxi- 
mately 50%, whereas BDNF transport o spinal 
cord was normal. 
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Figure 7. Retrograde Transport of ~251-Labeled Neurotrophins toDRG 
in LNR-Null Mice 
BALB/c (+/+) and LNR-null (-/-) mice were administered intraneural 
injections (0.4 pl; 18 ng) of lzSI-NGF (A), 1251-BDNF (B), or ~2SI-NT-4 
(C) and sacrificed 18 hr later. L4 and L5 DRG were counted, and the 
results are the mean _+ SD of 3-4 animals; for NT-4 and BDNF, the 
results are representative ofat least wo experiments. A marked reduc- 
tion of transport is observed for all three neurotrophins tested, with 
NT-4 and BDNF transport being the most severely reduced. 
transport of the neurotrophins to these neurons would be 
reduced also. Although this was observed, transport of 
the individual neurotrophins was not equally affected. 
Transport of ~z~I-NGF was reduced by 65% compared with 
wild type (Figure 7A). In contrast, transport of 1251-BDNF 
and ~251-NT-4 was more severely affected, showing reduc- 
tions of 82% and 93%, respectively (Figures 7B and 7C). 
These quantitative data were confirmed and extended by 
emulsion autoradiography, which allowed a comparison 
of the intensity of labeling by each neurotrophin in wild- 
type and LNR-null neurons. As in the rat, cellular labeling 
of wild-type DRG neurons was readily detected for the 
three neurotrophins tested. Transport of ~251-NGF to DRG 
neurons was less robust in LNR-null mice than in wild-type 
mice; however, numerous intensely labeled profiles were 
evident (Figures 8A and 8B). In contrast, the intensity of 
labeling by ~2SI-BDNF (Figures 8C and 8D) and ~251-NT-4 
(Figures 8E and 8F) was much lower in LNR-null neurons 
when directly compared with the wild type. Indeed, ~251-NT-4 
labeling was very sparse, with only a few cells display- 
ing silver grains above background levels. To rule out the 
possibility that the decreased transport of 1251-BDNF and 
12SI-NT-4 was due to a lack of TrkB in DRG of LNR-null 
mice, we analyzed TrkB protein expression by immu- 
noblotting. Aside from the full-length receptor, truncated 
forms of TrkB lacking the tyrosine kinase domain are pre- 
dominantly expressed by glial cells in DRG (McMahon et 
al., 1994). DRG from LNR-null mice contained immunore- 
active bands of 95 and 140 kDa (Figure 9A), which were 
identified as full-length and truncated TrkB proteins by 
preabsorption of the anti-TrkB antibody with a recombi- 
nant TrkB protein (Figure 9B). Laser densitometry re- 
vealed that the full-length TrkB (140 kDa) in LNR-null mice 
was comparable to that observed in the background 
strains (BALB/c and 129 mice). We confirmed the expres- 
sion of full-length TrkB in DRG sensory neurons of wild- 
type and LNR-null mice by performing in situ hybridization 
with a probe directed against the kinase domain of mouse 
TrkB (Klein et al., 1989). The results clearly show that 
expression of mRNA for full-length TrkB in LNR-null mice 
is comparable to that in the wild type (Figures 9C and 9D). 
Discussion 
Our studies demonstrate a specific role of LN R in the retro- 
grade transport of NT-4 and BDNF, but not NGF, in periph- 
eral neurons. Despite the recent discoveries of the Trk 
family of receptor tyrosine kinases and the signal transduc- 
tion cascades that they initiate in response to neurotro- 
phins, little is known about the receptor mechanisms that 
mediate signal transduction in a neuron in vivo. The nature 
of tissue cultu re studies may limit their usefulness in evalu- 
ating the actions of neurotrophins, to the extent that cells 
are exposed over their entire surface to neurotrophic fac- 
tors. This may result in direct stimulation of Trk proteins 
expressed on the cell body and in generation of local sig- 
nal transduction cascades (as has been shown in Trk- 
transfected fibroblasts; e.g., Glass and Yancopoulos, 
1993), thus circumventing the need for retrograde signal- 
ing. Recent experiments with cultured trigeminal and no- 
dose sensory neurons from LNR-null mouse embryos re- 
vealed no alterations in survival responses to NT-4 or 
BDNF and a 2- to 4-fold reduction in the potency (but no 
change in efficacy) of NGF on trigeminal neurons (Davies 
et al., 1993b). Also, our preliminary results suggest that 
survival of cultured embryonic rat DRG neurons in re- 
sponse to NGF or NT-4 is not affected by the presence of 
anti-REX (R. C. and P. S. D., unpublished ata). However, 
neurotrophic factors are often acquired from distal regions 
Role of Low Affinity Neurotrophin Receptor In Vivo 
1207 
+/+ ../-- 
NGF 
BDNF 
NT-4  
D 
F 
Figure 8. Visualization of Radiolabeled Neurotrophin Transport in DRG of LNR-Null Mice by Emulsion Autoradiography 
Bright-field photomicrographs of DRG sections from BALB/c (A, C, and E) and LNR-null (B, D, and F) mice injected with ~2SI-NGF (A and B), 
~2SI-BDNF (C and D), or ~2~I-NT-4 (E and F). Sections from BALB/c (+/+) and LNR-null ( - / - )  mice injected with each neurotrophin were mounted 
on the same slide to ensure equal coating with emulsion as well as equal exposure and development imes. Note that he intensity and number 
of DRG neurons labeled for BDNF ant NT-4 are greatly reduced in LNR-null mice as compared with wild type. Bar, 23 p,m. 
that lie several centimeters from the cell body, and there- 
fore, retrograde transport of factors or activated receptor 
complexes to the cell body may be a necessary step in 
signal transduction processes (Curtis and DiStefano, 
1994). We propose that LNR functions in vivo to mediate 
the retrograde transport of certain neurotrophins in distinct 
neuronal populations. 
Evidence for Selective Involvement of LNR in 
Retrograde Transport of Neurotrophins 
In the present study, we show that he retrograde transport 
of NT-4 and, to a lesser extent, BDNF by sensory neurons 
is highly dependent on a receptor mechanism involving 
LNR. This is supported by both direct and indirect experi- 
mental evidence. In cross-competition experiments, high 
doses of NGF are able to compete for the transport of 
1251-NT-4 to sensory neurons. Since NGF is not a TrkB 
ligand (Squinto et al., 1991), this suggests that the compe- 
tition for NT-4 transport may be mediated by binding of 
NGF to LNR. At lower doses, NGF potentiates the trans- 
port of NT-4 and BDNF; this may also occur by a mecha- 
nism involving LNR occupancy, such as positive coopera- 
tivity. Indeed, positive cooperativity of binding to LNR has 
been demonstrated for BDNF (Rodriguez-T6bar et al., 
1990) and NGF (Venkatakrishnan et al., 1990). 
Further support for differential involvement of LNR in 
neurotrophin transport comes from anatomical studies. 
The retrograde transport of NT-4 is correlated with the 
expression of LNR by sensory as well as motor neurons. 
In DRG neurons, retrograde accumulation of 12SI-NT-4 oc- 
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Figure 9. TrkB Protein and mRNA in DRG of 
LNR-Null Mice 
(A) Western blot analysis of full-length and trun- 
cated TrkB in DRG of BALB/c and 129 (+/+) or 
LNR-null (-/-) mice. The apparent molecular 
weights of full-length and truncated TrkB are 
140 and 95 kDa, respectively. Laser densitom- 
etry revealed that the full-length TrkB in LNFI- 
null mice was 83% and 147% of that seen i  
BALB/c and 129 mice, respectively. 
(B) The Western blot assay is specific for TrkB 
since coincubation ofthe primary anti-TrkB an- 
tibody with 50-fold excess (w:w) recombinant 
TrkB extracellular domain (+TrkB) greatly at- 
tenuates both full-length and truncated TrkB 
signals compared with the control (CONT). 
(C-E) In situ hybridization of mRNA for full- 
length TrkB in DRG from 129 (C) and LNR-null 
(D) mice. Hybridization to LNR-null DRG with 
the sense strand revealed no cellular labeling 
(E). Note that the intensity of the hybridization 
(silver grains) in the mutant (D) is comparable 
to that in the wild type (C). Bar, 100 p.m. 
curs primarily in cells expressing LNR, as assessed by 
192-1gG immunocytochemistry. With regard to motor neu- 
rons, we have shown here that NT-4 does not retrogradely 
accumulate in intact motor neurons, but does do so follow- 
ing axotomy (see Figure 3). The induction of LNR in le- 
sioned motor neurons (Ernfors et al., 1989; Rende et al., 
1992) coincides with the retrograde transport of NT-4. 
Also, motor neurons of wild-type mice, but not those of 
LNR-null mice, were able to transport NT-4 1 day after 
axotomy (data not shown). Consistent with this, NT-4 main- 
tains the cholinergic phenotype of injured motor neurons 
in adult rats (Friedman et al., 1995). During embryonic and 
postnatal development, motor neurons also express LNR 
(Ernfors et al., 1989) and are capable of retrogradely trans- 
porting NT-4 (Koliatsos et al., 1994). Cultured embryonic 
motor neurons are responsive to NT-4 (Wong et al., 1993), 
and pharmacological dministration of NT-4 rescues neo- 
natal facial motor neurons from death after axotomy (Koli- 
atsos et al., 1994). Accordingly, distribution and transport 
of 12SI-NT-4 in CNS tissues occurs only where TrkB and 
LNR are colocalized (Wiegand et al., 1994, Soc. Neurosci., 
abstract). It is important o consider the possibility that 
peripheral and central neuronal populations differ in their 
interactions with a given neurotrophin and in the degree 
to which LNR is utilized for retrograde transport. In this 
regard, transport of BDNF has been observed to neuronal 
populations in adult rats that apparently do not express 
LNR (DiStefano et al., 1992), such as uninjured motor neu- 
rons and a variety of cells within the CNS (Yan and John- 
son, 1989; Rende et al., 1992). This would also explain 
why motor neurons in LNR-null mice show no altered trans- 
port of BDNF compared with the wild type. 
To assess directly a role for LNR in retrograde transport 
of the neurotrophins, we neutralized endogenous LNR by 
utilizing either function-blocking antibodies or a soluble 
extracellular domain of LNR. There were striking differ- 
ences between the neurotrophins in response to these 
manipulations of LNR. Indeed, the rank order sensitivity 
of the neurotrophins to these agents showed that the retro- 
grade transport of NT-4 to DRG sensory neurons was dra- 
matically reduced, whereas that of NGF was only mini- 
mally affected. It is important o note that this differential 
sensitivity is not restricted to DRG sensory neurons but 
is observed in several other types of peripheral neurons 
as well. Accordingly, the transport of NT-4 to trigeminal 
sensory neurons was blocked by manipulations of LNR; 
this population of sensory neurons has been shown to 
respond to NT-4 in vitro (Ib~.Sez et al., 1993). Furthermore, 
the transport of NGF to sympathetic and trigeminal sen- 
sory ganglia was not affected by sLNR or anti-REX. 
We examined the characteristics of retrograde transport 
in a mouse strain with a null mutation of the LNR gene. 
In agreement with the pharmacological manipulations 
mentioned above and with LNR colocalization studies (see 
Figure 2), the retrograde transport of NT-4 in LNR-null 
mice was greatly diminished compared with that of NGF. 
This is not due to a lack of TrkB protein or mRNA expres- 
sion in DRG of LNR-null mice (see Figure 9). Full-length 
TrkB is restricted to neurons within DRG and is coex- 
pressed with either TrkA or TrkC in most neurons, making 
it unlikely that TrkB-expressing neurons would be selec- 
tively vulnerable to developmental cell death (McMahon et 
al., 1994). Consistent with our findings of relatively normal 
NGF transport in LNR-null mice, the NGF-dependent sym- 
pathetic neurons appear normal in these animals (Lee et 
al., 1992), apart from reduced innervation of a small num- 
ber of targets (Lee et al., 1994). 
Mechanisms of LNR Involvement in 
Retrograde Transport 
The results of the present study clearly show that LNR 
acts differentially to mediate the retrograde transport of 
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the neurotrophins. There are at least three potential stages 
in retrograde axonal transport at which LNR could act to 
mediate selectively this process, namely binding, uptake, 
and translocation. It is possible that the Trk proteins inter- 
act differentially with LNR even though no heterodimers 
of LNR and Trk proteins have been demonstrated (Jing 
et al., 1992; Meakin et al., 1992). LNR is itself internalized 
and retrogradely transported in peripheral nerve axons 
(Johnson et al., 1987), and a monoclonal antibody directed 
against LNR (192-1gG) augments the transport of NGF in 
sympathetic neurons (Taniuchi and Johnson, 1985), rais- 
ing the possibility that LNR coul(~ enhance the uptake and 
coupling of certain neurotrophin-Trk complexes to the ret- 
rograde transport machinery; however, this model does 
not explain the observed selectivity of LNR with regard to 
retrograde transport of neurotrophins. In support of differ- 
ential interaction of LNR with Trk proteins, cotransfection 
of fibroblast cell lines with LNR and TrkB results in greater 
cell growth than does cotransfection of cells with LNR and 
TrkA (Hantzopoulos et al., 1994). 
It is most likely that LNR execs differential effects on 
retrograde transport at the level of the binding event. Stud- 
ies have documented that LNR, in combination with TrkA, 
results in enhanced cell surface binding of 1251-NGF (Hemp- 
stead et al., 1991; BatUeman et al., 1993; Mahadeo et al., 
1994). Thus, LNR could promote an enhanced binding 
affinity that would in turn facilitate uptake of neurotrophins 
into the nerve terminal. Radioligand binding analyses have 
shown that, while all the neurotrophins bind to LNR with 
equal affinities, there are differences in the dissociation 
rates. Thus, dissociation is fastest for NGF, followed by 
NT-3 and BDNF (Rodriguez-T~bar et al., 1990, 1992). The 
dissociation rate constant for the binding of NTo4 to LNR 
is currently unknown. Interestingly, this rank order for dis- 
sociation rate constants parallels the rank order potency of 
12Sl-labeled neurotrophin transport inhibition by anti-REX 
and sLNR (BDNF > NT-3 > NGF). It is possible that slower 
dissociation rates stabilize the BDNF-LNR complex (or 
NT-4-LNR complex) on the neuronal surface, resulting in 
enhanced uptake. In other studies, mutation of critical ba- 
sic residues in a hairpin loop of NT-4 resulted in a mutant 
that did not bind to LNR and displayed 10-fold lower po- 
tency (but equal efficacy) on the survival of E16 rat DRG 
neurons (Ryd~n et al., 1995). Similar mutations in BDNF, 
NT-3, or NGF resulted in reduced binding to LNR but no 
loss of biological activities (IbdSez et al., 1992; Ryddn et 
al., 1995), supporting the notion that, among the neuro- 
trophins, NT-4 shows the greatest dependence on LNR 
for functional signaling. 
In addition to differences in direct binding parameters 
of various neurotrophins, the apparent selectivity of LNR 
for neurotrophin transport may lie in the ratio of Trk:LNR 
in a given cell. Mahadeo et al. (1994) reported that high 
affinity binding sites arise in neurons when LNR is in 10- 
fold excess over TrkA and that cells transfected solely with 
TrkA express only the lower affinity site. It is therefore 
conceivable that the TrkA:LNR ratio in DRG exceeds a 
critical level, obviating the need for LNR in retrograde 
transport of NGF via TrkA. Conversely, the ratio of TrkB: 
LNR may be lower and approximate a ratio that is more 
suitable for LNR interactions. In this situation, disturbing 
the level of LNR with high doses of NGF (1 p,g) or anti-REX 
may render TrkB incapable of proper binding and uptake 
of NT-4 or BDN F. Likewise, low doses of N GF (10 ng) may 
occupy excess LNR molecules and optimize the TrkB:LNR 
ratio, leading to the observed potentiation of NT-4 and 
BDNF transport by NG F. This potentiation may be of physi- 
ological significance when NGF is present in the same 
compartment as NT-4 or BDNF, such as in distal nerve 
or select target regions (Funakoshi et al., 1993; Ib&Sez et 
al., 1993; Timmusk et al., 1993). 
Experimental Procedures 
Iodlnation of Neurotrophins and Other Proteins 
Recombinant human NGF was obtained from R&D Systems (Minneap- 
olis, MN). BDNF and NT-3 were provided by AmgenlRegeneren Part- 
ners, and NT-4 was produced in E. coil as previously described (Fandl 
et al., 1994). LIF was the gift of Dr. James Miller (Aragon, Thousand 
Oaks, CA). WGA was purchased from Sigma (St. Louis, MO). The 
neuretrophins (10 p.g each), LIF (6 p,g), and WGA (15 p.g) were iodinated 
by a modification of the lactoperoxidase method (DiStefano et al., 
1992) using carrier-free Na~2Sl (New England Nuclear, Boston, MA). 
Incorporation of 12~1 was routinely 70%-90%, and specific activities 
were in the range of 3000-4500 cpmlfmol for 12Sl-labeled neure- 
trophins, 1800-2400 cpm/fmol for ~2SI-LIF, and 50 cpm/pg for ~I-WGA. 
The biological activities of ~251-1abeled neurotrophins were verified by 
the chick DRG neurite outgrowth assay (Maisonpierre t al., 1990; 
Fandl et al., 1994) or by survival of Trk-transfected fibroblasts (Glass 
et al., 1991). 
Animal Surgery and Quantification of Retrograde Transport 
Adult male Sprague-Dawley rats weighing 150-200 g were obtained 
from Zivic-Miller, housed 2-3 per cage, and given food and water ad 
libitum on a 12:12 hr light:dark cycle. Rats were anesthetized with 
ketamine (50 mg/kg) plus xylazine (10 mg/kg), and the right sciatic 
nerve was exposed at the level of the tendon of the obturator internus 
muscle (designated obturator tendon). A 1 p_l solution containing 22- 
44 ng of 12Sl-labeled neurotrophin was injected into the sciatic nerve 
at the obturator tendon concomitantlywith I ILl of PBS or other reagents 
(neurotrophins, antibodies, or receptors; see below). In some animals, 
the sciatic nerve was crushed at the obturator tendon 1-7 days prior 
to injection. At 18 hr after injection, rats were sacrificed, and the L4 
and L5 DRG were removed, placed in 40/0 paraformaldehyde/PBS, 
and counted for 1 min in a',f counter. The L4-L5 segment of the spinal 
cord was also dissected and counted. 
For neurotrophin cross-competition studies, unlabeled neuretro- 
phins (10-1000 ng) were coinjected with the l~l-labeled proteins. For 
antibody inhibition studies, 0.31-10.5 p.g of rabbit anti-REX (Weskamp 
and Reichardt, 1991) or rabbit anti-mouse IgG (Organon Tecknika 
Corp., West Chester, PA) was coinjected with the iodinated neure- 
trophins; sLNR (DiStefano et al., 1991) was also coinjected with the 
iodinated neurotrophins at doses of 0.026-2.6 p.g. 
For transport o trigeminal sensory neurons, 2 ILl injections, con- 
sisting of 0.5 p.I of l~l-labeled neurotrophin (22 ng) with 1.5 p.I of PBS, 
anti-REX (10.5 p.g), or 1 p.g of unlabeled neuretrophin, were made at 
two sites in the right whisker pad. Trigeminal ganglia were removed 
and counted 15-16 hr later. Retrograde transport of 12SI-NGF to sympa- 
thetic neurons in the SCG was assessed 16-18 hr after injection of 
0.5 p.I of lz~I-NGF (22 ng) into the right anterior eye chamber along 
with 1.5 p.I of PBS, sLN R (2.6 p.g), anti-REX (10.5 p.g), or unlabeled NG F 
(1 p.g). LNR-null mice (Lee et al., 1992) and corresponding background 
strains (BALB/c or 129) were injected with 0.4 p.I of 12~l-labeled neuro- 
trephins (18 rig), I~I-LIF (11 ng), or lzsI-WGA (27 ng) into the right 
sciatic nerve at the obturator tendon. Mice were sacrificed 18 hr later, 
and tissues were treated as described above. 
Statistical analyses of the data were performed by ANOVA and 
Dunnett's post-hoc test. 
All animal use in this study was conducted in compliance with ap- 
proved institutional animal care and use protocols and according to 
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NIH guidelines (Guide for the Care and Use of Laboratory Animals, 
NIH publication no. 86-23, 1985). 
Emulsion Autoradiography 
Fixed samples of DRG and spinal cord were processed for emulsion 
autoradiography as described previously (DiStefano et al., 1992). LNR 
immunostaining was performed on some sections prior to dipping in 
emulsion. Sections were incubated overnight with 500 ng/m1192-1gG 
(Chandler et al., 1984) in PBS containing 10/0 bovine serum albumin 
and 1% normal horse serum. After washing in PBS, staining was visu- 
alized with biotinylated horse anti-mouse IgG and the ABC Elite kit 
(Vector, Burlingame, CA), using 3,3'-diaminobenzidine (Sigma) as the 
chromogen. 
In Situ Hybridization 
Mice were perfused transcardially with 4% paraformaldehyde in 100 
mM sodium phosphate (pH 7.4). DRG were dissected and sectioned 
as described above and probed with =S-labeled antisense and sense 
strands from the mouse TrkB kinase domain. These probes were tran- 
scribed from a PCR fragment (RNA Transcription Kit, Stratagene, La 
Jolla, CA) corresponding to bases 2767-3057 of the mouse TrkB se- 
quence (Klein et al., 1989). In situ hybridization was performed as 
described elsewhere (Friedman et al., 1992). 
TrkB Western Blot 
DRG from 3 BALB/c and 129 mice or 7 LNR-null mice were dissected 
and homogenized on ice in 1 ml of lysis buffer (20 mM Tris, 1% Nonidet 
P-40, 150 mM NaCI, 50 mM NaF, 5 mM benzamidine, 1 mM EDTA, 
1 mM phenylmethylsulfonyl fluoride, 10 p.g/ml leupeptin, 10 p.g/ml 
aprotinin [pH 7.6]). Expression of full-length and truncated TrkB pro- 
teins was assayed by wheat germ lectin-agarose precipitation and 
Western blotting as described (KnLisel et al., 1994) using a rabbit anti- 
TrkB antibody ('rransduction Labs, Lexington, KY) and ECL detection 
(Amersham, Arlington Heights, IL). In blocking experiments, anti-TrkB 
antibodies were preincubated for 30 min with 12.5 I~g/ml soluble TrkB 
extracellular domain. This reagent was purified from insect cells in- 
fected with a TrkB extracellular domain-bacculovirus construct (pro- 
vided by Terrence Ryan and Nancy Tobkes). 
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